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Abstract
Background: The serotonin 2A receptor is widely implicated in genetic association studies and remains an important
drug target for psychiatric, neurological, and cardiovascular conditions. RNA sequencing redefined the architecture of the
serotonin 2A receptor gene (HTR2A), revealing novel mRNA transcript isoforms utilizing unannotated untranslated regions
of the gene. Expression of these untranslated regions is modulated by common single nucleotide polymorphisms (SNPs),
namely rs6311. Previous studies did not fully capture the complexity of the sense- and antisense-encoded transcripts with
respect to novel exons in the HTR2A gene locus. Here, we comprehensively catalogued exons and RNA isoforms for both
HTR2A and HTR2A-AS1 using RNA-Seq from human prefrontal cortex and multiple mouse tissues. We subsequently tested
associations between expression of newfound gene features and common SNPs in humans.
Results: We find that the human HTR2A gene spans ~66 kilobases and consists of 7, rather than 4 exons. Furthermore,
the revised human HTR2A-AS1 gene spans ~474 kilobases and consists of 18, rather than 3 exons. Three HTR2A exons
directly overlap with HTR2A-AS1 exons, suggesting potential for complementary nucleotide interactions. The repertoire
of possible mouse Htr2a splice isoforms is remarkably similar to humans and we also find evidence for overlapping
sense-antisense transcripts in the same relative positions as the human transcripts. rs6311 and SNPs in high linkage
disequilibrium are associated with HTR2A-AS1 expression, in addition to previously described associations with
expression of the extended 5’ untranslated region of HTR2A.
Conclusions: Our proposed HTR2A and HTR2A-AS1 gene structures dramatically differ from current annotations, now
including overlapping exons on the sense and anti-sense strands. We also find orthologous transcript isoforms expressed
in mice, providing opportunities to elucidate the biological roles of the human isoforms using a model system.
Associations between rs6311 and expression of HTR2A and HTR2A-AS1 suggest this polymorphism is capable of
modulating the expression of the sense or antisense transcripts. Still unclear is whether these SNPs act directly on
the expression of the sense or antisense transcripts and whether overlapping exons are capable of interacting
through complimentary base-pairing. Additional studies are necessary to determine the extent and nature of
interactions between the SNPs and the transcripts prior to interpreting these findings in the context of
phenotypes associated with HTR2A.
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Background
The serotonin 2A receptor (5-HT2A) is a G protein-
coupled receptor (GPCR) that serves as a primary target
for serotonin signaling and is expressed on many cell types
in the brain and periphery. 5-HT2A remains of great scien-
tific interest due to its many roles in normal biological
functions, which include cerebral cortex excitability [1],
platelet aggregation [2], smooth muscle contraction [3],
vasoconstriction and dilation [4], inflammatory processes
[5], and hormone signaling [6]. Among the many tissues
expressing 5-HT2A, it is especially prevalent in the cere-
bral cortex, enriched at the apical dendrites of pyramidal
neurons [7, 8]. Commensurate with its broad biological in-
fluence, studies examining single nucleotide polymor-
phisms (SNPs) in the gene encoding 5-HT2A (HTR2A)
have identified more than 100 genotypic associations with
a wide range of phenotypes, especially brain-related disor-
ders [9]. Drugs that directly or indirectly modulate seroto-
nergic signaling through 5-HT2A receptors are used to
treat neuropsychiatric, neurologic, and cardiovascular
conditions, and 5-HT2A is an emerging drug target for a
variety of other indications [10–13].
Transcriptome profiling in human tissues has greatly
increased our appreciation for RNA isoform diversity,
revealing pervasive alternative splicing and transcrip-
tion start and termination sites for nearly all multi-
exon genes [14, 15]. Consequently, we can utilize this
information to better understand disease states and
tailor therapeutics [16], but this requires in-depth
characterization of RNA expression for important tar-
gets, such as HTR2A. Knowledge of the different exons
and mRNAs for HTR2A has evolved over the past
20 years. Human HTR2A complementary DNA (cDNA)
was first cloned in 1991 (GenBank X57830.1) [17],
followed in 1992 by a genomic structure consisting of 3
exons spanning 20kB [18]. The original Reference Se-
quence (RefSeq) mRNA annotation (NM_000621.1) re-
flects these findings. Since this first annotation, HTR2A has
undergone three revisions, which removed cloning sites
and altered alleles at polymorphic sites (NM_000621.2),
added a 5’ exon (NM_000621.3), and extended the 3’ un-
translated region (UTR), adding a consensus polyadenyla-
tion signal (NM_000621.4). The current gene model
consists of 4 exons, spanning more than 65kB, and also
includes evidence for alternative splicing of exon 2
(NM_001165947). Based on length, these two RefSeq an-
notations (NM_000621.4 and NM_001165947.2) likely re-
flect the transcripts detected by Northern blot in 1990
[19]. There are additional HTR2A splice variants described
in the literature that are not yet annotated in RefSeq. This
includes an RNA isoform containing a novel 118-bp exon
residing in intron 3 of the current annotation [20] and four
additional exon boundary changes resulting in novel RNA
isoforms: a truncated exon 2, a retained intron between
exons 1 and 2, a 5’ extension of exon 1, and a 3’ extension
of exon 4 [21].
The HTR2A locus also hosts a long non-coding RNA
(lncRNA) gene on the antisense strand, annotated as
HTR2A-AS1 in RefSeq, and encoding two alternatively
spliced isoforms (NR_103752 and NR_046612). Four
Expressed Sequence Tags (ESTs) (AI076014.1, AI216351.1,
AI914390.1, and AW469493.1) suggest the existence of at
least three different splice variants, some of which are de-
tectable following PCR amplification of cDNA synthesized
from human brain and testes [21, 22]. Furthermore,
HTR2A-AS1 expression is readily detectable in human tes-
tes according to RNA-Seq data from the Genotype-Tissue
Expression (GTEx) project [23]. However, expression is
sparse in other GTEx-investigated tissues, including the
cerebral cortex (www.GTExportal.org).
The 5-HT2A gene in mice spans approximately 66kB on
chromosome 14 and contains 3 exons. The mouse gene
shares many similarities with the human gene. For ex-
ample, the relative genomic spacing of the protein-coding
exons and the use of constitutive splice sites is conserved,
such that the mouse exon 1/human exon 2 both encode
the first 138 amino acids of 5-HT2A, followed by a rela-
tively short intron (2.6kB in mouse, 2.9kB in human).
Mouse exon 2/human exon 3 both encode the subsequent
67 amino acids, followed by a relatively large intron
(60.4kB in mouse, 56.8kB in humans). Mouse exon 3/hu-
man exon 4 both encode the remaining 266 amino acids.
However, mouse Htr2a currently lacks in-depth analysis
of RNA isoform expression to delineate alternative tran-
scripts, as previously performed on human HTR2A.
Therefore, it is unclear how well the mouse recapitulates
the molecular biology of human HTR2A splice variants,
limiting its capacity as a model organism for understand-
ing HTR2A expression.
At the crux of the many genotype-phenotype associa-
tions involving HTR2A is whether the implicated genetic
variants have functional consequences. The most fre-
quently cited SNPs in studies concerning HTR2A are
rs6311 and rs6313. rs6311 and rs6313 are in near-perfect
linkage disequilibrium (LD) [24], located 1538 bases apart
on chromosome 13, and neither alter the encoded protein.
rs6311 (also known as -1438G >A and A-1438G) is his-
torically described as being located in the upstream or
promoter region of HTR2A. However, rs6311 is tran-
scribed in minor isoforms of HTR2A mRNA expressed in
the brain, perhaps through the use of an alternative tran-
scription start site that results in an extended 5’ UTR [21].
The variant “A” allele of rs6311 is associated with reduced
expression of isoforms containing this 5’ UTR extension.
rs6311 has also been correlated with total HTR2A mRNA
and protein expression [25, 26], although multiple studies
failed to find an allele-specific effect of rs6311 on the most
abundant primary transcript isoform [21, 27, 28]. rs6313
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(also known as T102C) is a synonymous SNP residing in
exon two. Because rs6313 lacks strong functional evidence
and is in high LD with rs6311, genetic associations with
rs6313 are often attributed to the functional consequences
of rs6311.
Understanding the functional consequences of SNPs is a
critical first step towards appreciating their roles in dis-
ease. To date, only a single study has examined HTR2A
SNPs and the expression of the extended 5’ UTR isoform
in affected tissues, finding no difference between post-
mortem brain tissue from autistic individuals and controls
[29]. To better understand the role of HTR2A in human
disease, here we have comprehensively catalogued the
transcripts expressed from the HTR2A gene locus in the
dorsolateral prefrontal cortex (DLPFC) from unaffected
controls and schizophrenia patients. We also character-
ized Htr2a locus expression in the mouse, contrasting it
with our human findings to determine where mice could
provide models for studying human 5-HT2A function. Fol-
lowing, we asked whether rs6311 and rs6313 are associ-
ated with sense or antisense transcript expression.
Results
HTR2A exons defined by splice junction analysis
In addition to the four annotated exons, we found evi-
dence for four different alternative exons, including two
that have not been previously described (exons 0 and 3b;
Table 1). The revised gene model is presented in Fig. 1b.
The majority of exon-exon junction reads join exons
from previously annotated isoforms. However, novel
exons also share splice junctions with the previously an-
notated exons, suggesting that they are included in ma-
ture RNA transcripts (Table 2; Additional file 1: Figure
S1). The strength of predicted splice donor/acceptor
sites and branch point sequences, assessed in silico using
the Human Splicing Finder (http://www.umd.be/HSF/)
[30], do not significantly differ across the novel and
annotated exons (Additional file 2: Figure S2a). Further-
more, the stretch of nucleotides 5 to 40 bases upstream of
the novel exons, presumably the polypyrimidine tracts, are
more highly enriched for pyrimidine and uracil nucleotides
relative to the annotated exons (Additional file 2:Figure
S2a). We also used the Alternative Splice Site Predictor
(http://wangcomputing.com/assp/index.html) [31] to iden-
tify and score any possible splice donor and acceptor site
across the entire HTR2A locus. We subsequently com-
pared scores at annotated and novel exons versus all other
predicted donor and acceptor sites in HTR2A. Again, we
found that average scores for the novel exons did not sig-
nificantly differ from the annotated exons, which both
scored higher than all other predicted donor/acceptor sites
(Additional file 2: Figure S2b).
Exons 1, 1int, 1ext, and 0 do not have exon-exon junc-
tions defining their 5’ boundaries and are therefore con-
sidered as transcription initiation sites. The parsimonious
interpretation based on RNA-Seq coverage in this area
supports the existence of two transcription start sites.
Transcripts containing exons 0, 1ext, and at least some of
1int likely use a transcription initiation site upstream of
the annotated exon 1, consistent with previous reports
[21]. However, the majority of transcripts likely utilize the
transcription initiation site beginning with exon 1, given
the large increase in read depth at this exon (Additional
file 3: Figure S3). Exons 3b and 4 do not have exon-exon
junctions defining their 3’ boundaries. Exon 4 contains a
canonical poly-adenylation (poly-A) signal (AATAAA) at
position chr13:47405698-47405703, after which the num-
ber of mapped reads drops off precipitously, signaling the
termination of the major transcript isoform(s) (Additional
file 4: Figure S4). Consistent with previous findings, we
observed a continuation of the 3’ UTR that extends be-
yond the canonical poly-A signal [21], continuing 5.6kB
distally from the annotated 3’ UTR to a cluster of four ca-
nonical poly-A signals within a stretch of 88 nucleotides
Table 1 HTR2A Exons
Exon Size (bp) Coordinatesa Notes
0 187 chr13:47472087-47472273 Newly described
1ext 1465 chr13:47470809-47472273 Described in Smith et al., 2013
1int 2644 chr13:47469630-47472273 Described in Smith et al., 2013
1 403 chr13:47470809-47471211 As annotated in RefSeq
2 740 chr13:47469630-47469825 As annotated in RefSeq
2tr 196 chr13:47469630-47470369 Described in Smith et al., 2013
3 201 chr13:47466525-47466725 As annotated in RefSeq
3a 118 chr13:47458674-47458791 Described in Guest et al., 2000
3b 1175 chr13:47456022-47457197 Newly described
4 4098 chr13:47405677-47409774 As annotated in RefSeq
4ext 9716 chr13:47400058-47409774 Partially described in Smith et al., 2013
aCoordinates reflect hg19/GRCh37
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(chr13:47400058-47400144; Additional file 4: Figure S4).
The lack of an exon-exon junction read to define the 3’
boundary of exon 3b suggests that it is unlikely to be
spliced into transcripts containing exon 4 and could rep-
resent a terminal exon. Reduced read coverage following a
cluster of canonical and non-canonical poly-A signals sup-
ports the interpretation that exon 3b is a terminal exon
(Additional file 5: Figure S5).
Transcript assembly for HTR2A
We assembled likely mRNA isoforms, excluding junc-
tions where we see only single junction counts. We then
assessed the predicted open reading frames and calcu-
lated the number of predicted transmembrane (TM) do-
mains (Table 3). Only transcript isoforms utilizing exons
2, 3, and 4 appear capable of translating protein isoforms
with all 7TM domains quintessential of GPCRs.
HTR2A-AS1 exons defined by splice junction analysis
HTR2A-AS1 is on the forward strand of chromosome 13.
Definition of HTR2A-AS1 splice junctions followed the
same rules regarding canonical splicing as applied to
HTR2A, allowing for stranded assignment of junction
reads. We first examined the transcriptome for evidence of
junction reads for the annotated HTR2A-AS1 gene. Only
the annotated exon 2 was identified through an exon junc-
tion read in this dataset. However, our analysis of exon-
exon junction reads across canonical exon boundaries
defined on the forward strand, agnostic to annotated
HTR2A-AS1 exons, identified 15 additional exons. Four of
these exons undergo apparent alternative splicing, resulting
in a total of 22 discretely defined exons (Fig. 1b; Table 4).
Fig. 1 Human HTR2A-AS1 (green) and HTR2A (blue) gene locus (chr13:47,370,678-47,844,384). a The current RefSeq annotation for HTR2A-AS1
includes three exons located within the third intron of HTR2A. b Splice junction analysis expands the number of exons for both HTR2A-AS1 to
include 18 total exons, three of which overlap with exons at the 5’ end of HTR2A (see Fig. 3). We also found evidence that supports extensions of
both untranslated regions, represented by the thinner blue bars at the terminal ends of the gene, and the addition of two exons (3a and 3b) for
HTR2A. Note: The panoramic view of HTR2A-AS1, represented on the first lines of figures A and B, have exons enlarged approximately 30-fold relative
to introns. The magnified loci between the red lines have exons and introns represented at a 1:1 scale. Arrows indicate the direction of transcription
Table 2 HTR2A Splice Junctions
Splices From: Splices To: Total Junction Countsa Samples Observed
0 2 28 21
0 2tr 1 1
0 3 126 73
0 4 1 1
1 or 1ext 2 15802 205
1 or 1ext 2tr 45 39
1 or 1ext 3 16 14
1 or 1ext 3b 1 1
2 or 1int 3 15253 200
2 or 1int 3b 1 1
3 3a 72 54
3 3b 39 34
3 4 or 4ext 14221 203
3a 3b 26 19
3a 4 or 4ext 108 60
aSummed across all samples
Table 3 Putative Transcript Assembly for HTR2A
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The frequency of these exon junction reads varied widely
(Additional file 6: Table S2), suggesting varying abundances
of many different HTR2A-AS1 splice isoforms. Notably,
multiple antisense exons overlapped sense-encoded HTR2A
exons (Fig. 3a). Exons 1, 2, 4, 5, 8, 9, 9.1, 10, 11, and 12 did
not have an exon junction read defining their 5’ boundary,
so we presume them to be transcription start sites. For
these exons, we have used Eponine [32] to predict and
score putative transcription start sites (Table 4). However, it
is also possible that these exons represent internal exons,
and we do not have adequate depth to capture all exon-
exon junctions, especially for exons with low expression.
One canonical poly-A signal was observed in exon 18.
Transcript assembly for HTR2A-AS1
From the 22 different HTR2A-AS1 exons we found to be
expressed in the DLPFC, we inferred the transcript iso-
forms by examining the number of incoming junction
reads spliced from upstream exons versus the outgoing
junction reads going to downstream exons. Furthermore,
we grouped junctions according to how often they were
observed (number of samples, number of junction reads)
into rare, low, medium, and high frequency groups, to aid
our inference of transcript isoforms (Additional file 6: Table
S2). Rare classification required only a single junction read
in a single sample. Low, medium, and high classifications
required a minimum of 2 reads in 2 samples, 25 reads in 25
samples, and 100 reads in 100 samples, respectively. Next,
we exhaustively assembled 57 models of possible HTR2A-
AS1 RNA isoforms, which begin at transcription start sites,
allow for only a single low coverage exon junction, and ter-
minate at exons 17 or 18 (Additional file 7: Table S3 and
HTR2A-AS1.FASTA). While we find it unlikely that 57 dif-
ferent transcripts are expressed from the HTR2A-AS1
locus, we used permissive criteria for assembly to next test
for protein-coding potential of any possible antisense tran-
script. The transcript isoform models range in size from
248 to 626 nt. From all possible transcripts, the longest pre-
dicted open reading frame (ATG-to-stop) is only 31 amino
acids long and is not supported as coding using the tcode
program in EMBOSS [33]. Therefore, we find it likely that
HTR2A-AS1 represents an lncRNA.
Mouse Htr2a and Htr2a-AS1 alignments
Using publically available RNA-Seq data generated from
a variety of mouse tissues (Gene Expression Omnibus;
Table 4 HTR2A-AS1 Exons
Exon Size Coordinates (hg19)a Predicted TSSb (hg19) TSS Scoreb Notes
1 71c chr13:47370678-47370748 chr13:47370715-47370719 0.8972
2 82c chr13:47426280-47426361 chr13:47426295-47426299 0.5747 As annotated in RefSeq
3 316 chr13:47428074-47428389 As annotated in RefSeq; No junction reads observed
3.1 144 chr13:47428074-47428217
4 139c chr13:47429408-47429546 chr13:47429250-47429253 0.2663
5 117c chr13:47429726-47429842 chr13:47429797-47429804 0.5568
6 210 chr13:47430225-47430434 As annotated in RefSeq; No junction reads observed
7 133 chr13:47466546-47466678 Overlaps HTR2A exon 3
7.1 194 chr13:47466546-47466739 Overlaps HTR2A exon 3
8 101c chr13:47469779-47469879 chr13:47469614-47469622 0.7864 Overlaps HTR2A exon 2
9 167c chr13:47471212-47471378 chr13:47471046-47471066 0.9737 Overlaps HTR2A exon 1ext
9.1 101 chr13:47471282-47471382 Overlaps HTR2A exon 1ext
10 101c chr13:47472971-47473071 chr13:47473021-47473029 0.7151
11 101c chr13:47474379-47474479 chr13:47474236-47474243 0.7058







18 69 chr13:47844316-47844384 Contains canonical polyA signal
aCoordinates reflect hg19/GRCh37
bScores are predicted by Eponine (Down & Hubbard, 2002) and includes 200 bp of upstream sequence. Only the highest score for each exon is reported
cNo 5’ exon junction is defined, so size is estimated based on local read depth
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GEO Accessions GSE36025, GSE52564, and GSE27243)
[34–36], we analyzed mouse Htr2a and Htr2a-AS1 ex-
pression in a manner similar to the human brain tissues.
The majority of reads mapped to the three annotated
exons for Htr2a. However, we also found evidence for
seven additional alternative sense-encoded exons (Add-
itional file 8: Table S4). In the mouse, Htr2a exons 1 and 2
can be alternatively spliced to form low-abundance iso-
forms orthologous to human transcripts (Additional file 9:
Figure S6). Of particular note, the highly-expressed arche-
type mouse isoform is orthologous to the human isoform
that retains intron 1. The mouse also expresses an ortho-
logue to the human isoform in which exon 2 is spliced
out. This is predicted to translate a protein that lacks the
first two transmembrane domains, consistent with the hu-
man isoform lacking exon 2. We also observed infrequent
utilization of the splice acceptor site equivalent to the
human exon 2 truncation (E2tr) that truncates the N-
terminus of 5-HT2A, resulting in a 6TM isoform. How-
ever, the splice donor site in mouse differs from that in
humans, resulting in a predicted protein that includes all
seven transmembrane domains, but lacks 71 of 75 amino
acids constituting the N-terminus. Finally, much like hu-
man HTR2A, the mouse gene has a well-expressed ex-
tended 3’ UTR, approximately 2.6kB longer than the
current annotation, terminating at a canonical poly-A site
(Additional file 10: Figure S7). The lack of a poly-A site
(canonical or non-canonical) at the end of the current an-
notation and the contiguous high expression into the ex-
tended 3’ UTR argues for revised annotation. As noted in
Additional file 8: Table S4 and Additional file 9: Figure S6,
we also see alternative splicing of the 3’ UTR, which is
predicted to shorten the protein by a single amino acid
and change three terminal amino acids (…NEKVSCV vs.
…NEKMPF). This alternative isoform also excludes a large
portion of the 3’ UTR, the significance of which is un-
known. Unlike human HTR2A, we do not see strong evi-
dence for an extended 5’ UTR in the mouse.
The mouse alignments suggest the presence of a low-
abundance antisense transcript, extending approximately
96 kB and comprised of up to 11 exons (Additional file 11:
Table S5; Fig. 2). This antisense transcript also shares simi-
larities to human HTR2A-AS1. In particular, the mouse ex-
presses antisense isoforms that overlap sense-encoded
exons of Htr2a and at similar positions as the human tran-
scripts (Fig. 3b). The functional role for the antisense in
regulating Htr2a function, if any, is not clear. However, the
similarities in overlapping sense and antisense exons be-
tween mouse and human tissue lend support for a con-
served regulatory function.
Genetic influence of HTR2A and HTR2A-AS1 expression
Guided by our newfound understanding of HTR2A and
HTR2A-AS1 gene structure, we tested the effects of the
phenotype-associated SNPs rs6311 and rs6313 on various
aspects of expression. To begin, we measured allelic RNA
expression to identify influences of cis-acting genetic vari-
ants. Specifically, we tested whether rs6311 confers an
allele-specific influence on the expression of the extended
5’ UTR. Previously, the ancestral “G” allele was associated
with increased expression relative to the variant “A” allele
[21, 29]. Eighty-two of 109 DLPFC samples heterozygous
rs6311had high-quality base calls over the rs6311 position,
but low coverage precluded allelic analysis on individual
samples. Instead we combined all of the reads at the
rs6311 position across the 82 samples, observing signifi-
cantly more reads of the “G” allele relative to the “A” allele
(187 vs 109 counts; binomial test p = 0.0004), consistent
with previous studies [21, 29]. We further tested whether
rs6313 or rs6311 influenced expression of the highly
expressed primary splice isoform in an allele-specific man-
ner by measuring allelic expression at rs6313. Greater
coverage at rs6313 allowed us to examine allelic expression
directly at this SNP in individual samples, rather than rely-
ing on pooled counts across samples. If rs6311 or rs6313
were responsible for driving allele-specific expression of
the primary transcript, our analysis should reveal imbal-
anced expression in most, if not all samples. However, only
9 of 109 samples heterozygous for rs6313 demonstrated
significantly imbalanced expression ranging from 1.83 to
2.87-fold differences in expression across alleles (Table 5).
The deviations from balanced expression suggest the pres-
ence of additional low frequency cis-acting regulatory vari-
ants, but argue strongly against a role for rs6311 or rs6313
in modulating expression of the highly-abundant HTR2A
mRNA isoform lacking the extended 5’ UTR.
In addition to direct allelic expression measures, we
tested whether rs6311 or rs6313 are significantly associated
with other HTR2A and HTR2A-AS1 expression measures,
analogous to expression quantitative trait loci (eQTL). This
included uniquely mapped reads covering all HTR2A or
HTR2A-AS1 exons, reads aligned to specific exons, and
Fig. 2 Mouse Htr2a-AS1 (green) and Htr2a (blue) gene locus (chr14: 74,607,947- 74,709,473). Currently, there is no mouse annotation for Htr2a-AS1
and the RefSeq annotation for Htr2a includes a shortened 3’ UTR as compared to gene model presented here (see Additional file 5: Figure S5).
Similar to human HTR2A, the antisense transcript in mouse overlaps Htr2a exons. Note: arrows indicate the direction of transcription
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junction reads for both HTR2A and HTR2A-AS1 in the
total DLPFC sample cohort. These analyses revealed no
significant genotype-expression associations for HTR2A
prior to Bonferroni correction. However, multiple aspects
of HTR2A-AS1 expression were significantly associated
with rs6311 and rs6313 genotypes, including total unique
HTR2A-AS1 reads, HTR2A-AS1 exon 14 and 17.1 reads,
and exon 14–17.1 junction reads (summarized in Table 6).
Only the genotypic effect on exon 14 reads remained sig-
nificant after strict Bonferroni correction. In all instances,
increased expression of HTR2A-AS1 is associated with the
variant alleles of rs6311 and rs6313 (A and T, respectively).
Discussion
Our analysis of RNA expression from the HTR2A gene
locus provides us with valuable insight into the sense-
and antisense-encoded genes of this region, and delin-
eates the use of known and novel exons. Of note, we see
evidence for expression of up to 10 distinct sense-
encoded human HTR2A exons generated through the
use of alternative transcription start sites, alternative
splicing (intron retention, alternative donor site), and
the infrequent use of novel splice donor/acceptor sites.
On the antisense strand, we observed an abundance of
novel HTR2A-AS1 exons. Including the previously-
described HTR2A-AS1 exons, our splice junction ana-
lysis provides evidence for up to 22 unique antisense
exons, 5 of which overlap with sense-encoded HTR2A
exons (Fig. 3a). Furthermore, we found evidence that the
common SNPs rs6311 and rs6313 are associated with
expression of the HTR2A transcripts with the extended
5’ UTR and HTR2A-AS1 exon 14. Finally, we demon-
strated that the expression of Htr2a and Htr2a-AS1 in
the mouse parallels expression in humans, suggesting
that the mouse is suitable for studying specific sense and
antisense isoforms.
Consequences of HTR2A alternative splicing
The genomics era, ushered in by massively-parallel DNA
sequencing, has rapidly expanded our knowledge of gene
architecture. At one time, nearly all GPCRs were consid-
ered to be without introns in their open reading frames
(ORFs) [37]. While GPCRs are enriched for intronless
ORFs relative to other protein classes, up to 42 % of rhod-
opsin family GPCR genes have multiple exons that undergo
alternative splicing [38]. Here, we found that HTR2A
undergoes a variety of different splicing events, including
utilization of alternative splice acceptor sites, exon skipping,
rare exon usage, and intron retention, similar to previously
described GPCR splicing patterns [39].
Inferred from splice junction reads, the majority of
HTR2A transcripts encode for the full-length 7TM recep-
tor (Table 3). However, some of the transcripts likely en-
code receptor proteins lacking the N-terminus and varying
stretches of transmembrane domains; particularly the iso-
forms with junctions shared between exon 0 and 3 and
those utilizing exon 2tr. The previously described 6TM
form resulting from usage of exon 2tr [21] bears resem-
blance to other GPCRs reported to have truncated or
“headless” forms: CALCR [40], CNR1 [41], CCKBR [42],
Fig. 3 Overlapping HTR2A (blue) and HTR2A-AS1 (green) exons in
human (A) and mouse (B). a Antisense exons 7, 8, and 9 overlap
human HTR2A exons 1, 2, and 3. Antisense exons 7 and 9 undergo
alternative splicing, resulting in 5 unique exons that can overlap HTR2A
transcripts. b Mouse antisense exons are situated similarly to the
human antisense exons. Note: orientation of the mouse genes are
reversed and mouse Htr2a exon 2 is aligned with human HTR2A exon
3 for comparison to the human genes. Arrows indicate the direction of
transcription. Thin blue bars represent untranslated regions, with the
hatched region of the human gene representing the extended 5’ UTR
Table 5 Significant Allelic Expression Imbalance at rs6313
Sample Diagnosis G alleles A alleles Binom Dist p-val Corrected p-val
1 Scz 92 36 3.94E-07 4.30E-05
2 Scz 79 31 2.67E-06 2.91E-04
3 Control 143 78 7.31E-06 7.96E-04
4 Scz 95 48 5.25E-05 5.72E-03
5 Scz 46 16 8.82E-05 9.61E-03
6 Scz 67 30 1.09E-04 1.19E-02
7 Control 69 32 1.48E-04 1.61E-02
8 Control 57 26 4.39E-04 4.78E-02
9 Scz 78 41 4.44E-04 4.84E-02
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Table 6 Associations Between rs6311 or rs6313 and RNA Expression
rs6311 rs6313
Gene G/G (n) G/A (n) A/A (n) P-Valuea Adjusted P-Value C/C (n) C/T (n) T/T (n) P-Valuea Adjusted P-Value
HTR2A-AS1 Unique Readsb 34.7 (69) 42.0 (106) 40.8 (26) 0.0070 0.4204 35.1 (73) 42.0 (103) 40.3 (25) 0.0153 0.9163
HTR2A Unique Readsc 4305.0 (71) 4525.7 (111) 3856.6 (26) 0.3026 1.0000 4262.2 (75) 4571.2 (108) 3934.5 (25) 0.3203 1.0000
HTR2A, AS1 Overlapping Readsd 69.9 (71) 75.8 (111) 62.0 (26) 0.3595 1.0000 69.2 (75) 75.8 (108) 63.9 (25) 0.4112 1.0000
Exon
HTR2A-AS1 Exon 14 Readse 13.2 (71) 17.2 (111) 16.7 (26) 0.0004 0.0212 13.4 (75) 17.2 (108) 16.6 (25) 0.0010 0.0586
HTR2A-AS1 Exon 17.1 Readsf 16.4 (69) 21.3 (106) 19.6 (26) 0.0011 0.0687 16.6 (73) 21.3 (103) 19.6 (25) 0.0030 0.1771
Junction Reads
HTR2A-AS1 Exon 14 to 17.1 Readsg 7.9 (69) 10.3 (108) 9.8 (27) 0.0069 0.4169 8.1 (73) 10.2 (105) 9.8 (26) 0.0142 0.8532
Count values in the table are model predicted least square means. Differences in the subject numbers across outcomes reflect missing data in the selected variables for each model
aCalculated using a negative binomial generalized linear model with selection of covariates via Bayesian Information Criterion (BIC)













OPRL1 [43], OPRM1 [44], and SSTR5 [45]. While a head-
less form of 5-HT2A would not necessarily disrupt the
binding site for serotonin, it could abate membrane expres-
sion due to the deletion of N-glycosylation sites [46]. A
comparison across species at the nucleotide level reveals
strong conservation beginning specifically at the splice ac-
ceptor site for exon 2tr and a relative lack of amino acid
conservation in the N-terminus across species (Additional
file 12: Figure S8). In our analysis of mouse Htr2a, we ob-
served usage of the exon 2tr splice site, which is predicted
to result in a 7TM receptor that lacks almost the entire N-
terminus. The N-glycosylation sites critical for 5-HT2A
membrane expression are conserved in mice, and are de-
leted by the use of the orthologous exon 2tr splice site. Con-
sequently, we speculate that membrane expression for the
truncated receptor would be reduced in mice and humans.
It is not known whether the alternatively spliced mRNAs
are translated into truncated 5-HT2A protein isoforms in
vivo, or subsequently capable of signaling from the cyto-
plasm. Assuming translation occurs, there are two observa-
tions arguing for the plausibility of intracellular 5-HT2A
signaling. First, serotonin that enters cells via the serotonin
transporter is biologically active and involved in “serotony-
lation” of proteins [47]. Second, GPCRs in the cytoplasm,
internalized via the endosome, can continue to signal
through G protein-dependent and independent mecha-
nisms [48]. Further studies characterizing the cell type-
specific and developmental expression patterns of this
truncated isoform could lend insights into the biological
relevance of this, and perhaps other, headless GPCRs.
HTR2A-AS1, a lncRNA
Long non-coding RNAs are stringently defined by their
length (>200 nt), lack of protein-coding potential, use of in-
dependent transcriptional units, presence of canonical
splice site signals, and ability to undergo alternative splicing
[49]. Some lncRNAs can have over 100 exons (SNURF-
SNRPN) [50] and many are species-specific [51, 52]. With
the additional exons and junctions we uncovered here, we
reassessed classification of HTR2A-AS1, firmly concluding
that it meets criteria as an lncRNA.
The question of HTR2A-AS1 function remains. lncRNAs
have diverse roles, but most characterized up to this point
influence transcription and processing of RNAs from
nearby genes, sometimes by direct RNA-RNA interactions,
and other times through epigenetic modifications [53]. The
fact that HTR2A-AS1 has exons directly overlapping with
HTR2A transcripts (Fig. 3a), a feature which is also appar-
ent in the mouse (Fig. 3b), argues strongly for the possibil-
ity of direct interaction through complementary nucleotide
base-pairing, assuming the sense- and antisense-encoded
transcripts are expressed at the same time and location.
Direct RNA-RNA interactions could influence RNA pro-
cessing, protein translation, or both. The relatively low
abundance of the antisense transcripts relative to the sense
isoforms and their apparent isoform diversity argues
against a role in translation of the major HTR2A protein
isoform, as these transcripts would have to exit the nu-
cleus, find their respective targets, and impact the function
of the translating ribosome.
Instead, we speculate that HTR2A-AS1 is more likely to
have roles in HTR2A mRNA expression or processing. The
variable use of 5’ exons in HTR2A-AS1 and Htr2a-AS1,
coupled with their conserved overlap with alternatively-
spliced HTR2A exons 1 and 2 (Fig. 3), could allow HTR2A-
AS1 to participate in the alternative splicing of HTR2A
through direct RNA-RNA interactions. Additionally, the
associations between the ancestral “G” allele of rs6311,
greater expression of HTR2A exon 1ext, and decreased ex-
pression of the seemingly constitutive HTR2A-AS1 exon
14 suggests a possible role in transcription start site usage
or epigenetic modifications, perhaps through RNA-DNA
interactions. In this case, we would presume that expres-
sion of the lncRNA is inversely associated with usage of
the transcription start site that results in longer 5’ UTR
HTR2A transcripts. It is also possible that HTR2A-AS1
transcripts impact HTR2A expression at multiple levels
and in a species-specific manner. While molecular data
showing an interaction of any kind between HTR2A-AS1
and HTR2A is lacking, our study provides critical informa-
tion for testing these hypotheses, including evidence that
an orthologous lncRNA is expressed in mice.
HTR2A and HTR2A-AS1 genetics: rs6311 and rs6313
HTR2A demonstrates many genotype-phentoype associ-
ations. A cursory analysis of the HuGE Navigator Geno-
pedia shows 201 disease terms where HTR2A was
investigated in 540 publications [54]. To put this into
perspective, of the 12,488 genes listed in the HuGE
Navigator, HTR2A ranks 58th with respect to the number
of associated disease terms. Of the 540 HTR2A publica-
tions listed, 333 specifically mention rs6311 or rs6313
(or some variation of the nomenclature; e.g. -1438 A/G,
T102C, etc.) in their abstract or title, highlighting the
interest in understanding disease associations conferred
by these SNPs. While contradictory findings for any one
phenotype-genotype association exist, overwhelming evi-
dence implicates HTR2A, and specifically rs6311 or
rs6313, in a variety of phenotypes.
Because rs6311 and rs6313 are in near perfect LD, gen-
etic association studies have the liberty of using either
SNP to obtain similar results. However, each SNP must be
considered separately when attempting to elucidate their
biological functions and contributions to disease. To date,
the most compelling evidence for modulating biological
function supports a role for rs6311 in the expression of
HTR2A mRNAs with the extended 5’ UTR [21, 29], while
no apparent role has been identified for rs6313. The allelic
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expression analysis of rs6311 in our current study sup-
ports the conclusion that rs6311 modulates expression of
the extended 5’ UTR. Aside from the infrequent allelic ex-
pression imbalances noted for rs6313, we find little evi-
dence that expression of the highly-expressed primary
HTR2A transcript not containing the extended 5’ UTR is
modulated by these common SNPs.
Regarding the transcription factors binding to the region
of DNA harboring rs6311 to exert an allelic effect, the
question remains open. An interesting candidate that uni-
tes genetic findings in schizophrenia is Early Growth Re-
sponse 3 (EGR3). Polymorphisms in the promoter of the
gene encoding EGR3 are implicated in schizophrenia [55].
Multiple studies have now demonstrated a link between
EGR3, 5-HT2A receptor expression, and schizophrenia-
like behaviors in transgenic animals [56, 57]. The consen-
sus binding site for EGR3 does align, although imperfectly,
at the rs6311 region and the minor allele for rs6311 im-
pacts this alignment (Additional file 13: Figure S9). Other
transcription factors predicted to bind at the rs6311 locus
in silico include the nuclear factor 1 family (NFIA/B/C),
the Thing1/e47 heterodimer, and SMAD3 (Additional file
13: Figure S9). However, molecular evidence and add-
itional bioinformatic studies are required to test such rela-
tionships, given the imprecision of transcription factor
binding site tools in predicting relationships in vivo.
Changes in expression conferred by rs6311 or rs6313
could also result from other RNA processing events,
such as alternative splicing. Considering the extent of
alternative splicing on both the sense and antisense
strands adjacent to rs6313, and the proximity of this
SNP to alternative exons, we find it possible that this
SNP could impact splicing. In silico analysis of splicing
factors using a number of tools suggest this SNP can
impact their binding (Additional file 14: Table S6).
However, the aggregated results do not demonstrate a
clear consensus for any single splicing factor being im-
pacted by rs6313.
Future studies of HTR2A-AS1 expression should con-
sider regulation by rs6311 or rs6313, as we found some
evidence suggesting differential expression across geno-
type. However, the low read coverage across the entire
HTR2A-AS1 transcript leads us to interpret these find-
ings with caution. Both SNPs sit in intronic regions of
HTR2A-AS1; rs6313 is 61 nucleotides downstream of
exon 8 and rs6311 is 100 nucleotides downstream of
exon 9. Both exons 8 and 9 share a relatively high
number of splice junctions with the antisense exon 14
that exhibits genotype-expression associations. Our
analyses are unable to isolate the individual contribu-
tions of either SNP due to high LD. Until stronger evi-
dence delineates specific roles for each SNP, it remains
equally plausible that either could modulate HTR2A-
AS1 expression.
Conclusions
We examined HTR2A and HTR2A-AS1 gene structure by
mapping RNA-Seq junction reads from human prefrontal
cortex, utilizing conventional definitions for exon struc-
ture independent of established gene annotations. This ap-
proach revealed two novel exons in HTR2A and showed
the extent to which all exons are included in the mature
mRNA transcripts. While the majority of transcripts con-
sist of the previously-annotated exons that encode for the
full-length 7TM protein, we also found evidence support-
ing the use of unannotated but previously-described exons
that likely form truncated protein isoforms of 5-HT2A. In
contrast, HTR2A-AS1 has numerous novel exons, some of
which overlap with annotated HTR2A exons. The bio-
logical significance of HTR2A-AS1 transcripts is yet to be
revealed, but the current findings enable studies to directly
test if they regulate HTR2A expression. To that end, we
conclude that the mouse could serve as a suitable model
organism for studying whether sense-antisense interac-
tions occur in Htr2a, as it also expresses many ortholo-
gous sense and antisense transcripts, and the overlapping
features between the transcripts are spatially similar. Fi-
nally, we found evidence that the common genetic variant
rs6311 regulates expression of HTR2A transcripts contain-
ing the extended 5’ UTR, consistent with previous studies.
We also found associations between rs6311, rs6313, and
expression of HTR2A-AS1. Guided by these findings, we
can begin to examine variable transcript expression in the




DLPFC specimens (Brodmann area 46/9) were dissected
by a trained neuropathologist (T.M.H.) from brains col-
lected post-mortem from the Office of the Chief Medical
Examiner of the State of Maryland, with audiotaped in-
formed consent from the legal next-of-kin, as approved
by the Maryland Department of Health and Mental Hy-
giene’s Institutional Review Board, as previously de-
scribed [58, 59]. Details of tissues acquisition, handling,
processing, dissection, clinical characterization, diagno-
ses, and neuropathological examinations were also previ-
ously described [58]. Research on post-mortem samples
was conducted in accordance with the U.S. Department
of Health & Human Services Code of Federal Regula-
tions (Title 45, Part 46), in which post-mortem research
is distinct from human subject research and not under
the purview of a local IRB (http://www.hhs.gov/ohrp/
humansubjects/guidance/45cfr46.html#46.102). Samples
were de-identified and include 105 schizophrenia patients
and 106 normal controls; 85 African Americans and 126
Caucasians (Demographics in Table 7). In accordance with
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known schizophrenia traits, smoking and suicide are no-
ticeably higher in the affected cohort.
Genotyping, illumina chips
Genomic DNA was extracted from cerebellar tissues
(Qiagen, Valencia CA, USA) and genotyped with Human-
Hap650Y_v3 or Human 1 M-Duo_v3 Illumina BeadChips
(Illumina, San Diego, CA, USA) according to the manu-
facturer’s instructions. Genotypes were called using the
Illumina GenomeStudio v2010.1 software using the de-
fault settings and the chip-specific cluster files supplied by
Illumina. For data analysis, SNPs had an overall missing
rate <0.02 %, CAUC and AA Hardy-Weinberg Equilib-
rium (HWE) p-values each > = 0.001, and minor allele fre-
quencies (MAF) > = 0.01.
RNA extraction and quality assessment
Tissue from DLPFC was pulverized and stored at -80 °C.
Total RNA was extracted from 100 mg of tissue with
TRIzol Reagent (Life Technologies, Grand Island, New
York). The yield of total RNA was determined by spec-
trophotometry by measuring absorbance at 260 nm.
RNA quality was assessed with high-resolution capillary
electrophoresis on an Agilent Bioanalyzer 2100 (Agilent
Technologies, Palo Alto, California), yielding an RNA
Integrity Number (RIN; scale 1–10, with 1 being the
lowest and 10 being the highest RNA quality).
RNA-Seq library construction
RNA-seq libraries were constructed using Illumina Tru-
Seq RNA sample Prep Kit, following the manufacturer’s
protocol. The poly-A containing mRNA molecules were
purified from ~ 800 ng DNAse treated total RNA. Fol-
lowing poly-A purification, the mRNA was fragmented
into small pieces using divalent cations under elevated
temperature (94°) for 2 min. Under this condition, frag-
ment lengths range from 130 to 290 bp with a median
length of 185 bp. Fragmented RNA was reverse tran-
scribed into a first strand cDNA-RNA hybrid using
random hexamers. Following, DNA Polymerase I and
RNaseH were used to generate the complementary sec-
ond strand cDNA. These double-stranded cDNA frag-
ments then underwent end repair using T4 DNA
polymerase, T4 PNK and Klenow DNA polymerase.
Illumina PE barcoded adapters were ligated using T4
DNA Ligase following the addition of a single ‘A’ base
using Klenow exo (3’ to 5’ exo minus). These products
were then purified and PCR-enriched to create the final
cDNA library for high through put DNA sequencing
using a Highseq2000. The concentrations of RNA-seq
libraries were measured by Qubit (Invitrogen, CA). The
quality of each RNA-seq library was measured by Lab-
ChipGX (Caliper, MA) using HT DNA 1 K/12 K/
HiSens Labchip.
Mouse tissues and sequencing
All mouse data was obtained from public sources. Mouse
tissues collection, RNA isolation, library preparation, and
RNA-Seq were performed as described in their original
publications [34–36]. Collected animal data conformed to
local institutional review boards, as described in their ori-
ginal publications [34–36]. Raw BAM files from each of
Table 7 Human Tissue Demographics
Schizophrenia (n = 105) Control (n = 106)
Gender Male 74.3 % (n = 78) 74.5 % (n = 79)
Female 25.7 % (n = 27) 25.5 % (n = 27)
Race Caucasian 60.0 % (n = 63) 59.4 % (n = 63)
African-American 40.0 % (n = 42) 40.6 % (n = 43)
Age at Death 45.6 ± 13.8 years 45.9 ± 13.8 years
Manner of Death Natural 59.0 % (n = 62) 82.1 % (n = 87)
Accidental 13.3 % (n = 14) 8.5 % (n = 9)
Suicide 26.7 % (n = 28) 0.0 % (n = 0)
Undetermined 1.0 % (n = 1) 0.9 % (n = 1)
No Autopsy 0.0 % (n = 0) 0.9 % (n = 1)
Homicide 0.0 % (n = 0) 7.5 % (n = 8)
Smoking Status at Time of Death Smoker 70.5 % (n = 74) 26.4 % (n = 28)
Non-smoker 21.0 % (n = 22) 70.8 % (n = 75)
Not Determined 8.6 % (n = 9) 2.8 % (n = 3)
Brain pH 6.46 ± 0.24 6.56 ± 0.26
Post-mortem interval 40.3 ± 26.6 hours 29.4 ± 14.1 hours
RNA Integrity Number 8.0 ± 0.91 8.3 ± 0.75
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the three studies (Series Numbers GSE27243, GSE52564,
and GSE36025) were downloaded from GEO (http://
www.ncbi.nlm.nih.gov/geo/) and aligned with GSNAP
as described below to Mus musculus reference genome
mm10.
RNA sequence mapping
Demultiplexing was performed with CASAVA v1.8.2
(http://support.illumina.com/sequencing/sequencing_soft-
ware/casava.ilmn). Alignments were first performed with
Tophat v2.0.4 [60] using the reference genome: Illumina
UCSC hg19; and gene annotations: Ensembl GRCh37.67.
An example command is: tophat –p 4 –r 160 –G Homo_-
sapiens.GRCh37.67.gtf –o Sample_out. Reads over the
HTR2A region were extracted post processing with sam-
tools v0.1.18 [61] with the following example command:
samtools view –h Sample_RNA/accepted_hits.bam chr13:
47357513-47521169 > HTR2A_regions/Sample_RNA/
accepted_hits.sam. The extracted reads for each of the
211 samples were subsequently re-aligned to the hu-
man genome reference with GSNAP [62] which allows
for gapped alignments, including intron-spanning align-
ments. Descriptive and statistical analyses were per-
formed using this subsequent alignment.
Alignment to the HTR2A locus
On average, we generated 114 million reads per sample,
82 % of which mapped to the reference genome (mapping
statistics in Additional file 15: Table S1). HTR2A is on the
reverse strand of chromosome 13. Consequently, we de-
fined canonical splice junctions with respect to transcrip-
tion on the reverse strand and subsequently mapped
junction reads across putative exons in order to define
exon boundaries. In order for reads at novel junctions to
be attributed to HTR2A, they must follow canonical spli-
cing rules such that the nucleotides comprising the pre-
sumptive splice donor and acceptor sites are GU and AG,
respectively. Adherence to this rule establishes the gen-
omic DNA strand from which transcription occurred,
eliminating ambiguity when assigning junction reads to
HTR2A versus the overlapping HTR2A-AS1. This resulted
in an average of 7248 aligned reads per sample over the
HTR2A locus. Observational analysis, for the purpose of
correcting for obvious bias in HTR2A mapping, revealed
no overt differences across diagnosis or sex with respect
to HTR2A expression.
RNA quantification
Gene expression was quantified using the total number of
reads for each sample that uniquely aligned to the refer-
ence. The read depth of each gene was computed based on
the coordinates of mapped reads and newly annotated
exons in the reference genome. Visualization of the map-
ping was carried out using publicly available software,
primarily the Integrated Genomic Viewer (IGV) (http://
www.broadinstitute.org/software/igv/).
Allelic expression imbalance
Allele-specific expression was assessed for those samples
that were heterozygous over rs6311 and rs6313. For meas-
uring quality base counts, we used the following command,
varying the region and sample: samtools mpileup -uD -r
chr13:47357513-47521169 -f ref_genome.fa R3924_*.bam |
bcftools view -cg - | grep 47469940. Read counts from the
DP4 field was used in a binomial statistical test with a 5 %
multiple test corrected significance cut-off.
In silico splicing and transcription factor binding analysis
Sequences 100 bp upstream and downstream of exons was
downloaded from UCSC Genome Browser and submitted
to the Human Splice Finder v2.4.1 in silico webserver
(http://www.umd.be/HSF/), which scores splicing charac-
teristics (splice donor site, acceptor site, branch point) [30].
For the branch point analysis, the highest scoring motif be-
tween positions -50 and -17 relative to the exon start site
was considered for analysis. Positions -40 to -5 were
analyzed for polypyrimidine frequency, expressed as a
percentage.
Splicing characteristics were also scored using the Al-
ternative Splice Site Predictor [31]. For this analysis, se-
quence for the entire HTR2A region was downloaded via
the UCSC Genome Browser and submitted to the web-
server (http://wangcomputing.com/assp/index.html) for
scoring. We compared the average of scores obtained for
annotated RefSeq exons vs. newly-discovered exons vs.
all other predicted splice donor/acceptor sites using in-
dependent sample t-tests. In-depth analysis of splicing
events for rs6313 alleles used multiple in silico tools for
predicting putative splicing-related proteins [63–67].
Transcription factor binding for rs6311 alleles was per-
formed using MatInspector (http://www.genomatix.de/
matinspector) [68].
Statistical methods
A natural choice to model read counts is the Poisson distri-
bution. However, it has been shown that Poisson distribu-
tion does not capture biological variation in read counts
[69–71]. To account for the extra variation found in bio-
logical replicates, the Poisson distribution can be extended
through the negative binomial distribution, which has been
used extensively to model RNA-Seq data [72, 73]. Thus, a
generalized linear model (GLM) with logit link function
using the negative binomial distribution was used to
analyze read counts. The genotypic model was log(Unique-
lyMappedReads*ExpressionRate) = Covariates + SNP. The
best set of covariates was chosen using the model that
minimized the Bayesian Information Criterion. Covariates
considered were age, race, gender, diagnosis, alcohol use,
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smoking status, PMI, brain pH, RIN, and suicide. The brain
pH and RIN were the main covariates explaining significant
amounts of read count variability and were included in
most models. Multiplicity correction was performed using
a Bonferroni adjustment for the number of endpoints
tested times the effective number of independent SNPs
tested [74], to control type I error at an experiment-wise
alpha level of 0.2.
Availability of supporting data
Human DLPFC RNA-Seq and genotyping data will be
available for download in early 2016 according to the
data sharing policy described Schubert et al. (2015) [75].
Mouse data used in this study can be downloaded from
GEO at http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?
acc=GSE27243 [34], http://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc=GSE52564 [35], and http://www.ncbi.
nlm.nih.gov/geo/query/acc.cgi?acc=GSE36025 [36]. Map-
ping software used in the current study includes
CASAVA 1.8.2 (http://support.illumina.com/sequencing/
sequencing_software/casava.ilmn), TopHat 2.0.4 (https://
ccb.jhu.edu/software/tophat/index.shtml) [60], samtools
v0.1.18 (http://samtools.sourceforge.net/) [61], and GSNAP
(http://research-pub.gene.com/gmap/) [62]. Aligned .BAM
files were viewed using IGV (https://www.broadinstitu-
te.org/igv/). Splicing analyses were performed using Human
Splice Finder v2.4.1 (http://www.umd.be/HSF/) [30], Alter-
native Splice Site Predictor (http://wangcomputing.com/
assp/index.html) [31], SpliceAid2 (http://www.introni.it/
splicing.html) [63], Rescue-ESE (http://genes.mit.edu/bur-
gelab/rescue-ese/) [64], FAS-ESS (http://genes.mit.edu/fas-
ess/) [65], SFmap (http://sfmap.technion.ac.il) [66], ACES-
can (http://genes.mit.edu/acescan2/) [67]. Transcription
factor analysis was performed using MatInspector (http://
www.genomatix.de/matinspector) [68].
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